WallStreetZenWallStreetZen

NASDAQ: CNTX
Context Therapeutics Inc Stock Forecast, Predictions & Price Target

Analyst price target for CNTX

Based on 1 analyst offering 12 month price targets for Context Therapeutics Inc.
Min Forecast
$4.00+189.86%
Avg Forecast
$4.00+189.86%
Max Forecast
$4.00+189.86%

Should I buy or sell CNTX stock?

Based on 1 analyst offering ratings for Context Therapeutics Inc.
Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their CNTX stock forecasts and price targets.

CNTX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-03-21

1 of 1

Forecast return on equity

Is CNTX forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
37.27%

Forecast return on assets

Is CNTX forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

CNTX revenue forecast

What is CNTX's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$6.6M
Avg 2 year Forecast
$28.3M
Avg 3 year Forecast
$53.8M

CNTX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
CNTX$1.38$4.00+189.86%Buy
NRSN$1.82N/AN/A
ONTX$1.01$11.00+989.11%Buy
LUMO$2.82$22.00+680.14%Buy
GLTO$0.78N/AN/A

Context Therapeutics Stock Forecast FAQ

Is Context Therapeutics Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: CNTX) stock is to Buy CNTX stock.

Out of 1 analyst, 0 (0%) are recommending CNTX as a Strong Buy, 1 (100%) are recommending CNTX as a Buy, 0 (0%) are recommending CNTX as a Hold, 0 (0%) are recommending CNTX as a Sell, and 0 (0%) are recommending CNTX as a Strong Sell.

If you're new to stock investing, here's how to buy Context Therapeutics stock.

What is CNTX's revenue growth forecast for 2028-2030?

(NASDAQ: CNTX) Context Therapeutics's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 39.22%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.52%.

Context Therapeutics's revenue in 2024 is $0.On average, 1 Wall Street analysts forecast CNTX's revenue for 2028 to be $105,375,950, with the lowest CNTX revenue forecast at $105,375,950, and the highest CNTX revenue forecast at $105,375,950. On average, 1 Wall Street analysts forecast CNTX's revenue for 2029 to be $451,839,300, with the lowest CNTX revenue forecast at $451,839,300, and the highest CNTX revenue forecast at $451,839,300.

In 2030, CNTX is forecast to generate $858,973,651 in revenue, with the lowest revenue forecast at $858,973,651 and the highest revenue forecast at $858,973,651.

What is CNTX's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: CNTX) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is CNTX's Price Target?

According to 1 Wall Street analyst that have issued a 1 year CNTX price target, the average CNTX price target is $4.00, with the highest CNTX stock price forecast at $4.00 and the lowest CNTX stock price forecast at $4.00.

The Wall Street analyst predicted that Context Therapeutics's share price could reach $4.00 by Mar 21, 2025. The average Context Therapeutics stock price prediction forecasts a potential upside of 189.86% from the current CNTX share price of $1.38.

What is CNTX's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: CNTX) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.